We are happy to announce that #Sugammadex API has been approved by Japanese authorities
27/05/2024
We are happy to announce that #Sugammadex API has been approved by Japanese authorities (DMF Registration number: 305MF10019). The launch quantities have already been sent to our partners in #Japan.
Sugammadex Sodium is an injectable solution used to reverse neuromuscular blockade during anesthesia. Medichem is a vertically integrated manufacturer of this product, supplying both the Active Pharmaceutical Ingredient (API) and Finished Dosage Form (FDF). Our API plant in Malta offers a strategic advantage to our customers by enabling early market entry. This integrated approach ensures efficient and timely access to this critical medical solution.
Would you like to receive more information? Feel free to contact us at bd@medichem.es.
